Renaissance Technologies
MGRM

Renaissance Technologies’s Monogram Orthopaedics MGRM Stock Holding History

Renaissance Technologies’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,300
Closed -$111K – 3930
2023
Q4 		$111K Buy
+32,300
New +$97.4K ﹤0.01% 3280

Other funds holding MGRM

FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies's MGRM Position: Q1 2024 in Review

Renaissance Technologies sold out of Monogram Orthopaedics (MGRM) in Q1 2024, closing a stake of 32,300 shares — an estimated $111K sold.

Renaissance Technologies first reported a position in MGRM in Q4 2023 and held it in 1 quarter. The position peaked at $111K in Q4 2023. 29 funds tracked by Wall St. Rank hold MGRM as of Q1 2024.

  • Renaissance Technologies reported no remaining Monogram Orthopaedics position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 32,300 Monogram Orthopaedics shares in Q1 2024, an estimated $111K.
  • Renaissance Technologies first reported a position in Monogram Orthopaedics in Q4 2023 and held it in 1 quarter.
  • Renaissance Technologies's Monogram Orthopaedics position peaked at $111K in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.